Skip to content
2000
Volume 6, Issue 1
  • ISSN: 1574-3624
  • E-ISSN: 2212-389X

Abstract

Growth Arrest Specific1 (Gas1) is a protein expressed during development and when cells arrest their growth. The potential of Gas1 as an adjuvant in the treatment of cancer, and its role as a tumor suppressor have also been proposed. We had previously demonstrated the structural relationship between Gas1 and the α receptors for the Glial-cell line-Derived Neurotrophic Factor (GDNF) family of ligands, and showed that Gas1 acts by inhibiting the intracellular signaling induced by GDNF, reducing both the pattern of autophosphorylation of Ret and the activation of AKT, thus inducing cell arrest and apoptosis. On the other hand, it has also been proposed that Gas1 positively interacts with Sonic Hedgehog (Shh) during embryonic development. In this review we will critically evaluate the data regarding the molecular mechanisms of action of Gas1, and discuss that the potential therapeutic effects of Gas1 treating cancer are related with its capacity inhibiting the intracellular signaling cascade induced by GDNF.

Loading

Article metrics loading...

/content/journals/cst/10.2174/157436211794109433
2011-01-01
2025-09-29
Loading full text...

Full text loading...

/content/journals/cst/10.2174/157436211794109433
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test